Login / Signup
Duane H Hamilton
ORCID
Publication Activity (10 Years)
Years Active: 2023-2024
Publications (10 Years): 5
Top Topics
Machine Learning
Poor Prognosis
Mesenchymal Stem Cells
Cancer Therapy
Top Venues
Journal for immunotherapy of cancer
Cancer immunology, immunotherapy : CII
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Jeffrey Schlom
,
Renee N Donahue
,
Claudia Palena
,
Sofia R Gameiro
,
James W Hodge
,
Duane H Hamilton
,
James L Gulley
Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines.
Journal for immunotherapy of cancer
12 (7) (2024)
Jeffrey Schlom
,
Renee N Donahue
,
Claudia Palena
,
Sofia R Gameiro
,
James W Hodge
,
Duane H Hamilton
,
James L Gulley
Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines.
Journal for immunotherapy of cancer
12 (7) (2024)
Jeffrey Schlom
,
Renee N Donahue
,
Claudia Palena
,
Sofia R Gameiro
,
James W Hodge
,
Duane H Hamilton
,
James L Gulley
Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines.
Journal for immunotherapy of cancer
12 (7) (2024)
Jeffrey Schlom
,
Renee N Donahue
,
Claudia Palena
,
Sofia R Gameiro
,
James W Hodge
,
Duane H Hamilton
,
James L Gulley
Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines.
Journal for immunotherapy of cancer
12 (7) (2024)
Maria Del Mar Maldonado
,
Jeffrey Schlom
,
Duane H Hamilton
Blockade of tumor-derived colony-stimulating factor 1 (CSF1) promotes an immune-permissive tumor microenvironment.
Cancer immunology, immunotherapy : CII
(2023)